We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Emergent Biosolutions Inc | NYSE:EBS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.42 | -3.75% | 10.78 | 11.18 | 10.72 | 11.09 | 309,187 | 14:57:03 |
--A mix-up at a U.S. factory will delay distribution of the Johnson & Johnson Covid-19 vaccine, the New York Times reported.
--The NYT said that workers at the Baltimore plant had accidentally conflated the vaccine's ingredients weeks ago and ruined about 15 million doses of Johnson & Johnson's vaccine.
--The plant is run by Emergent BioSolutions, a manufacturing partner to Johnson & Johnson and AstraZeneca PLC, the NYT said.
--Johnson & Johnson vaccine doses currently being delivered and used nationwide were produced in the Netherlands and are not affected, the NYT reported, adding that all further shipments of the Johnson & Johnson vaccine were supposed to have come from the Baltimore plant and are now in question while the quality control issues are sorted out.
In after-hours trading, Johnson & Johnson shares were down 0.33% at $163.81, while Emergent Solutions' stock was down 4.85% at $88.40.
Full story: https://www.nytimes.com/live/2021/03/31/world/covid-19-coronavirus#johnson-and-johnson-vaccine-mixup
(END) Dow Jones Newswires
March 31, 2021 18:13 ET (22:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Emergent Biosolutions Chart |
1 Month Emergent Biosolutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions